Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL7L1 pseudogene 18 is a non-coding genomic locus highly homologous to the protein-coding ribosomal protein L7-like 1 gene (RPL7L1). Pseudogenes, including RPL7L1P18, do not produce functional proteins and are not considered classical therapeutic targets. Their biological and clinical relevance derives primarily from sequence homology rather than direct effects; in rare cases, pseudogene transcripts may modulate cellular biology by acting as competing endogenous RNAs, but such functions have not been documented for RPL7L1P18 specifically[4]. The parent RPL7L1 gene is implicated in cancer biology (especially tumor proliferation, migration, apoptosis inhibition, and immunosuppressive microenvironments)[1][3]. However, all information associating RPL7L1 with disease, biomarkers, or therapeutic response is specific to the functional gene, not to its pseudogenes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RPL7L1 pseudogene 18 (RPL7L1P18).